As shown in Figure 6(b), the combination of decursin and doxorubicin downregulated the phosphorylation of p-mTOR and its downstream S6 K1 in the three multiple myeloma cells but did not affect PI3 K and Akt signaling (data not shown). Here, MTOR is linked to plasma cell myeloma.